Clinical Trial Update: BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada [Phase 3]

View source ↗

Summary

Phase 3 trial comparing boosted atazanavir (Reyataz) to lopinavir/ritonavir (Kaletra) each with fixed-dose Truvada in treatment-naive HIV-1 patients; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)
• REYATAZ (atazanavir)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2011-05-09